Despite the short term attachment preference of angiosarcoma cells to fibronectin, the cells eventually adhered to collagen IV within a 24 hour period, yet mitogenic and survival signaling such AKT, AMPK, and MAPK/CDK pathways remained substantially enhanced on fibronectin compared to collagen IV substrates. The gene discussed is FN1; the disease is angiosarcoma.